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Purpose: Suture placement and alkali burn to the cornea are often used to induce inflammatory corneal neovascularization
(CorNV) models in animals. This study compares the changes in genome-wide gene expression under these two CorNV
conditions in mice.
Methods: CorNV were induced in Balb/c mice by three interrupted 10–0 sutures placed at sites about 1 mm from the
corneal apex, or by alkali burns that were 2 mm in size in the central area of the cornea. At the points in time when
neovascularization progressed most quickly, some eyeballs were subjected to histological staining to examine CorNV and
inflammatory  cells  infiltration,  and  some  corneas  were  harvested  to  extract  mRNA  for  microarray  assay.  After
normalization and filtering, the microarray data were subject to statistical analysis using Significance Analysis of
Microarray software, and interested genes were annotated using the Database for Annotation, Visualization, and Integrated
Discovery (DAVID) program. The expression change of classical proangiogenic molecule like vascular endothelial growth
factor (VEGF) and antiangiogenic molecule like pigment epithelium-derived factor (PEDF) was further verified using
western blotting.
Results: Suture placement induced CorNV in the areas between the suture and limbus, but did not affect the transparency
of the yet unvasuclarized areas of the corneas. In contrast, alkali burn caused edema and total loss of transparency of the
whole cornea. Histology showed that sutures only caused localized epithelial loss and inflammatory infiltration between
the suture and limbus, but chemical burn depleted the whole epithelial layer of the central cornea and caused heavy cellular
infiltration of the whole cornea. At day 5 after suture placement, 1,055 differentially expressed probes were identified,
out of which 586 probes were upregulated and 469 probes were downregulated. At a comparable time point, namely on
day 6 after the alkali burn to the corneas, 472 probes were upregulated and 389 probes were downregulated. Among these
differentially  expressed  probes,  a  significant  portion  (530  probes  in  total,  including  286  upregulated  and  244
downregulated probes) showed a similar pattern of change in both models. Annotation (using DAVID) of the overlapping
differential genes revealed that the significant enrichment gene ontology terms were “chemotaxis” and “immune response”
for the upregulated genes, and “oxidation reduction” and “programmed cell death” for the downregulated genes. Some
genes or gene families (e.g., S100A family or α-, β-, or γ-crystallin family) that had not been related to corneal pathogenesis
or neovascularization were also revealed to be involved in CorNV. VEGF was upregulated and PEDF was stable as shown
with western blotting.
Conclusions: Sutures and alkali burn to the corneas produced types of damage that affected transparency differentially,
but gene profiling revealed similar patterns of changes in gene expression in these two CorNV models. Further studies of
the primary genes found to be involved in CorNV will supplement current understanding about the pathogenesis of
neovascularization diseases.
Neovascularization, referring to the growth of abnormal
vessels, is caused by the disruption of the balance between
proangiogenic  and  antiangiogenic  molecules  [1-3].  It  is  a
common pathological process observed in tumor growth and
metastases,  rheumatoid  disease,  and  corneal  and  retinal
disorders.  Generally,  the  most  intensively  studied
proangiogenic molecules include vascular endothelial growth
factor (VEGF), basic fibroblast growth factor (bFGF), and
interleukin-8 (IL-8), as well as the antiangiogenic molecules
including  angiostatin,  endostatin,  pigment  epithelium–
derived factor (PEDF), and so on. Specifically in cornea, the
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avascularity of corneas is a necessity for corneal transparency
and relies on some properties of this tissue [4-7], like the
expression of soluble VEGF receptor [8]. Some disorders,
such as infections, degeneration, graft rejection, misuse of
contact lenses, and chemical or physical damage, all can lead
to loss of balance and can induce corneal neovascularization
(CorNV). Though CorNV is a programmed response aimed
at recovering homeostasis in insulted corneas, CorNV impairs
vision. Thus, its prevention or correction is needed in most
cases. The mechanisms of CorNV are sophisticated and are
not clearly understood yet, and many studies on CorNV at the
molecular  level  are  based  on  knowledge  about
neovascularization in other tissues or in other pathological
processes.  To  create  a  picture  of  gene  expression  at  the
genomic scale during the development of CorNV, microarray
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2386was used in two popular experimental CorNV models, namely
suture placement and chemical burn induced CorNV in mice
(S-CorNV and CB-CorNV). These two artificial etiological
factors  are  believed  to  produce  inflammatory  process
associated with CorNV pathogenesis after insults to cornea,
like  trauma,  dry  eye,  chemical  burn,  etc.  Microarray
technology was chosen because of its strength in monitoring
the expression of thousands of genes in a high-throughout
manner, as well as in a quantitative manner. We expected that,
besides  uncovering  the  behavior  of  those  conventional
proangiogenic or antiangiogenic factors in CorNV, this study
would also reveal some genes that had not been related to
CorNV,  thus  providing  new  clues  to  understanding  the
pathogenesis of CorNV.
METHODS
Animals:  Balb/c  mice,  6–8  weeks  old,  were  used  in  this
research.  All  mice  were  purchased  from  Beijing
Pharmacology  Institute,  Chinese  Academy  of  Medical
Sciences (Beijing, China). Use of animals was approved by
institution and observed the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research.
Corneal neovascularization models: Mice were anesthetized
with ketamine (50 mg/kg) and chlorpromazine hydrochloride
(10  mg/kg)  by  intraperitoneal  injection.  Compound
tropicamide  eye  drops  (Santen,  Osaka,  Japan)  and  0.5%
proparacaine  hydrochloride  (Alcon-Couvreur,  Puurs,
Belgium)  were  applied  topically  for  corneal  anesthesia.
CorNV was induced by suture placement or chemical burn, as
previously described by others [9]. Briefly, a corneal trephine
2 mm in diameter was pressed lightly on the central cornea to
make a circular mark. Three interrupted 10–0 polypropylene
sutures (MANI Inc., Togichi, Japan) spanning the mark were
placed through the epithelial and stromal layers, but without
penetrating the endothelial layer. To cause alkali burn to the
cornea, a piece of filter paper (2.0 mm in diameter) soaked
Figure 1. Gross and histology presentations of corneas of corneal neovascularization models. A: Front views and side views of corneas with
corneal neovascularization under slit lamp. B: Hematoxylin-eosin staining of corneas at limbus area and junction area, the latter of which
refers to the area of the suture stitch in the S-corneal neovascularization model and the margin of direct chemical burn. The red scale bar
represent 50 μm. Please note the difference of manifestations in these two models, especially in terms of transparency of the corneas.
TABLE 1. GROUPING OF PROBES EXPRESSED IN AT LEAST ONE CORNEAL NEOVASCULARIZATION MODEL.
  S-CorNV
CB-CorNV Up-Reg Unchanged Down-Reg Absent
Up-Reg G1: 286 G4: 99 0 G9: 87
Unchanged G2: 203 0 G6: 186 0
Down-Reg 0 G5: 114 G7: 244 G10: 31
Absent G3: 97 0 G8: 39 0
        In each individual microarray, probes were identified as E (expressed), M (marginal), or A (absent) in an individual array after
        linearization and normalization as described in text, and only those classified as E were calculated for ratio values of the signal
        intensities of experimental samples against controls in the same arrays. For statistical purposes, probes marked as E in only one
        of three microarrays in one model were classified as A in this table. Down-Reg meant a signal intensity ratio of the experimental
        sample/control ≤0.5 plus FDR<1%, and Up-Reg meant ≥2.0 plus FDR<1%. Unchanged was for those of 0.5<ratio<2 or
        FDR>1%.
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2387Figure 2. Hierarchical clustering of all
1,386 differentially expressed probes in
either  the  S-  or  the  CB-corneal
neovascularization model. The color bar
located in upper left corner stands for the
folds of probe changes (in log2 value),
while the gray color in the heat maps
indicates that the value was absent in a
specified  microarray.  S,  suture;  CB,
chemical burn.
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2388with 2 μl of 1 mol/l NaOH solution was placed on the central
corneal surface for 40 s, followed by immediate rinsing with
30 ml of 0.9% saline buffer.
Histology:  Mice  eyeballs  were  formalin  ﬁxed,  paraffin
embedded, and sectioned at a thickness of 4 μm for routine
histological processing. After staining with hematoxylin and
eosin, vessels and cell infiltration were examined by light
microscopy.
Isolation  of  total  RNA  and  microarray  procedure:  The
procedure for total RNA isolation and microarray assay was
described earlier [10]. In brief, at the desired time points after
CorNV  induction,  corneas  were  excised  using  a  2  mm
diameter  trephine  and  placed  in  ice-cold  TRIzol  reagent
(Invitrogen, Gaithersburg, MD), with five corneas from each
model pooled into one sample. The untreated corneas from
the same mice were used as controls. Three pairs of samples
were prepared for each model. Total RNA was extracted using
isopropanol precipitation and was purified using NucleoSpin
RNA clean-up columns (Macherey-Nagel, Düren, Germany).
Dual  cRNA  labeling  and  microarray  hybridizations  were
performed  by  Capital  Bio  Corporation  using  Capital  Bio
cRNA labeling kits and the Capital Bio 36 K Mouse Genome
Figure 3. Change of expression of PEDF and VEGF detected by
western blot in corneal neovascularization. Samples were harvested
at day 5 after S-CorNV induction and proteins of equivalent to one
fifth cornea were loaded and detected by western blot. Please note
that due to differential levels of two factors in samples, the exposing
time of blotted membrane against X-films varied, namely about 45
s for PEDF, 2 min for GAPDH, and about 1 h for VEGF. Shown was
one  representative  of  three  experiments  that  gave  similar
conclusions.
Oligo Array (Capital Bio, Beijing, China) [11,12]. The array
comprises 35,852 70-mer oligonucleotide probes representing
approximately 25,000 genes of Mouse Genome Version 4.0
(Operon Biotechnologies, Huntsville, AL). Three replicate
arrays were used for each model. After hybridization, the
arrays were scanned using a LuxScan 10KA (Capital Bio),
and  signals  were  processed  with  LuxScan  3.0  software
(Capital Bio). Intra-array normalization was done using the
LOcally  Weighted  Scatter  plot  Smoothing  (LOWESS)
linearization method. Inter-array normalization of the whole
data set was performed according to the global means of Cy5
and Cy3 signals [12].
Microarray  data  analysis:  In  each  array,  the  probes  that
passed various quality check and gave signal intensity of over
1,500  were  labeled  as  Expressed,  otherwise  a  probe  was
considered Marginal (intensity 800–1500) or Absent (less
than 800). Only those probes that were expressed in at least
two out of three chips were taken into account for further
analysis. After log2 transformation of the fold values, one class
t-test analysis was performed by Significance Analysis of
Microarray software SAM 3.0 (Stanford University, Stanford,
CA) [13] to determine their change or stability in the CorNV
group compared with the control group. Those genes that gave
less than a 1% false discovery rate (FDR) and no less than
twofold  changes  were  considered  to  be  differentially
expressed  genes.  Last,  the  differentially  expressed  genes
identified  in  each  CorNV  model  were  compared  and
annotated using the Database for Annotation, Visualization
and  Integrated  Discovery  (DAVID,  v6.7)  with  the  whole
murine genome as the background [14]. Gene Ontology (GO)
categorization was performed using a modified Fisher exact
test, and the p value for each GO category was calculated as
a expression analysis systematic explorer (EASE) score [15].
An EASE score of not more than 0.01 indicated a significant
enrichment.  Hierarchical  clusters  were  performed  for
different sets of interested genes using the Cluster 3.0 program
with the Pearson correlation (uncentered) distance, average
linkage [16,17], and the resulting CDT files transferred into
heat maps using Java Treeview [18]. The complete sets of
normalized data of this microarray assay are deposited in the
NCBI  Gene  Expression  Omnibus  (GEO)  with  a  GEO
accession number GSE23347.
Antibodies and western blotting: Corneas were harvested by
cutting along the centric side of limbal line and placed in RIPA
lysis buffer (Beyotime, Shanghai, China) for total protein
preparation. For each sample, two corneas were combined and
100 μl buffer were used. The tissues was cut with scissors into
small pieces and homogenized using a tissue tearor (Biospec
Products, Inc., Bartlesville, OK). After spinning at 11,500× g
for 10 min, 80 μl cleared lysate were mixed with 20 μl 5×
loading buffer. After boiling at 95 °C for 5 min, 10 μl samples
were resolved on 12% SDS–PAGE gel and then transferred
to a polyvinylidene difluoride (PVDF) membrane (Millipore,
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2389TABLE 2. ENRICHED GENE ONTOLOGY TERMS ACCORDING TO BIOLOGIC PROCESS IN VARIOUS GROUPS OF GENES.
Enriched GO terms in each group Counta
G1 group: upregulated in both S-CorNV and CB-CorNV
Cell migration
chemotaxis (see Table 3) 18
leukocyte chemotaxis 9
leukocyte migration 10
locomotory behavior 18
cell migration 12
Host defense responses
immune response (see Table 4) 32
defense response 29
inflammatory response (see Table 5) 21
response to wounding 25
acute inflammatory response 10
acute-phase response 6
response to organic substance 16
response to molecule of bacterial origin 5
antigen processing and presentation of exogenous antigen 6
immunoglobulin mediated immune response 7
B cell mediated immunity 7
lymphocyte mediated immunity 7
positive regulation of response to stimulus 10
regulation of cytokine production (see Table 6) 8
regulation of tumor necrosis factor production 4
response to oxidative stress 6
response to cytokine stimulus 4
positive regulation of acute inflammatory response 3
positive regulation of multicellular organismal process 8
cytokine-mediated signaling pathway 5
defense response to Gram-negative bacterium 3
Tissue development or organization
eye development 10
lens development in camera-type eye 5
multicellular organismal homeostasis 6
extracellular structure organization 8
regulation of biomineral formation 4
regulation of bone mineralization 4
regulation of homeostatic process 6
cellular cation homeostasis 8
collagen fibril organization 4
homeostatic process 17
cellular homeostasis 12
vasculature development 10
epidermis development 7
sensory organ development 10
ectoderm development 7
epithelium development 10
epithelial cell differentiation 7
lens fiber cell differentiation 3
cellular iron ion homeostasis 4
positive regulation of developmental process 9
blood vessel development (refer to Table 7) 10
Metabolism
intermediate filament-based process 4
icosanoid biosynthetic process 4
unsaturated fatty acid biosynthetic process 4
icosanoid metabolic process 4
G2 group: upregulated in S-CorNV, unchanged in CB-CorNV
mitosis 8
nuclear division 8
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2390Billerica, MA). The blots were blocked in 5% non-fat dry milk
dissolved in TBST (20 mM Tris PH7.5, 0.5 mM NaCl, 0.05%
Tween-20)  for  1  h  and  then  incubated  with  the  primary
antibody in TBST for 2 h, followed by incubation with HRP-
conjugated secondary antibody for 1 h. All incubations were
done at room temperature and three washes with 10 ml TBST
were applied between each step. Primary antibodies include
anti-mouse  PEDF  antibody  (sc-25594;  Santa  Cruz
Biotechnology Inc., Santa Cruz, CA), anti-VEGF antibody
(ab-3109;  Abcam  Biotechnology,  Cambridge,  MA).
TABLE 2. CONTINUED.
Enriched GO terms in each group Counta
organelle fission 8
M phase 9
cell cycle phase 9
G3 group: upregulated in S-CorNV, absent in CB-CorNV
not any  
G4 group: unchanged in S-CorNV, upregulated in CB-CorNV
chordate embryonic development 9
embryonic development ending in birth or egg hatching 9
endothelial cell morphogenesis 2
G5 group: unchanged in S-CorNV, down-regulated in CB-CorNV
not any  
G6 group: down-regulated in S-CorNV, unchanged in CB-CorNV
Lipid metatolism
lipid biosynthetic process 15
steroid metabolic process 12
steroid biosynthetic process 8
cholesterol metabolic process 7
carboxylic acid biosynthetic process 8
organic acid biosynthetic process 8
fatty acid biosynthetic process 6
oxidation reduction 16
Host response
cellular response to extracellular stimulus 5
cellular response to starvation 4
epithelium development 9
Differentiation
epithelial cell differentiation 6
epidermis development 6
keratinocyte differentiation 4
epidermal cell differentiation 4
Wnt receptor signaling pathway 6
ectoderm development 6
regulation of neuron differentiation 5
G7 group: down-regulated in both S-CorNV and CB-CorNV
oxidation reduction (see Table 9) 19
programmed cell death 14
retinol metabolic process 3
G8 group: down-regulated in S-CorNV, absent in CB-CorNV
not any
G9 group: absent in S-CorNV, upregulated in CB-CorNV
response to organic substance 10
response to steroid hormone stimulus 4
immune response 8
oxidation reduction 9
icosanoid metabolic process 3
G10 group: absent in S-CorNV, down-regulated in CB-CorNV
not any  
“Enrichment” means that a specific GO terms gives an Expression Analysis Systematic Explore (EASE) score less than 0.01.
To simplify the presentation of the enriched terms, the GO terms that obviously duplicate others were not shown. For example,
“cellular response to nutrient levels” in Group 6 was not shown due to its duplication to “cellular response to starvation.”
Similarly, “Cell death,” “death,” and “apoptosis” in Group 7 were duplicates of “programmed cell death,” thus not shown either.
aNumbers of probes in the specific group or GO term.
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2391Secondary  antibodies  include  Peroxidase-Conjugated
AffiniPure Goat Anti-Rabbit IgG (H+L; ZB-2301; Zhongshan
Golden Bridge, Beijing, China) and Peroxidase-Conjugated
AffiniPure Anti-Mouse IgG (ZB-2305, Zhongshan Golden
Bridge).The blot was developed with SuperSignal West Pico
(NCI5079,Thermo  Fisher  Scientific,  Rockford,  USA)  and
exposed to X-ray film (Kodak, Rochester, NY). For detecting
GAPDH,  the  PVDF  membrane  was  regenerated  using
Stripping  Solution  (Applygen  Technologies  Inc.,  Beijing,
China)  and  detected  using  an  GAPDH  detection  kit
(KC-5J5,KangChen  Biotechnology,  Shanghai,  China)  as
suggested by the manufacturer.
RESULTS AND DISCUSSION
Corneal neovascularization in two models: Both S-CorNV
and CB-CorNV have been used successfully, including in our
laboratory  [10,19],  when  studying  either  mechanisms  of
CorNV development or interference from exogenous factors
in the development of CorNV. The conclusions drawn using
one model are presumed to be applicable to all CorNV. We
previously used both models without any specific preference;
by contrast, this study tried to define any commonalities or
differences  between  these  two  models.  Clinically,  suture
placement did not cause other significant changes to corneal
transparency  except  for  the  development  of
neovascularization, but chemical burn caused total loss of
transparency of the burned area, starting from the burn (Figure
1A). Later, the haze extended from the edge of the burn to the
limbus. The difference in the gross appearance of corneas in
these two models correlated with the histological changes
(Figure 1B). While the suture did not affect the intactness of
the epithelial layer in areas other than the suture punch, the
chemical burn depleted the entire epithelial layer of the central
corneas. Correspondingly, the suture caused inflammatory
infiltration limited to the area between the suture and limbus,
but the chemical burn caused heavy infiltration and edema of
the whole cornea. In spite of the significant gross difference
in these two models, the appearance and progress of CorNV
in chemically burned corneas was slightly slower than that in
sutured corneas. S-CorNV progressed most quickly at day 5,
and CB-CorNV at day 6 (Figure 1), reaching maximal length
at day 10 and day 14, respectively (data not shown). This paper
focused  on  data  obtained  at  the  fast-growth  time  points,
namely day 5 for the suture and day 6 for the chemical burn,
respectively.
Comparison of differentially expressed genes in two corneal
neovascularization models:  Merely by checking the gross
presentation or histology of corneas in these two conditions
as described above, we expected CB-CorNV to affect the
expression of more genes or to affect them to a greater extent
than  S-CorNV  would.  However,  gene  profiling  using
microarray showed that S-CorNV affected gene expression
more  than  did  CB-CorNV.  Among  all  the  35,872  probes
(excluding various controls) in this chip, 7,138 that passed the
filter criteria were identified as being expressed in S-CorNV,
and 7,109 in CB-CorNV, for a total of 7,766 probes expressed
in at least one model. Namely, about 92% of all expressed
probes  were  detected  in  both  models,  reflecting  the
consistency and reliability of the data sets. Statistical analysis
using SAM software, with the thresholds set at FDR<1% and
fold change≥2, revealed that 1,055 probes (accounting for
14.78% of all expressed genes in the S-CorNV model) were
TABLE 3. GENES ASSOCIATED WITH THE GENE ONTOLOGY TERM “CHEMOTAXIS” IN THE UPREGULATED GENE LIST.
Ref_Seq ID Gene
symbol
Gene name S-CorNV folds CB-CorNV folds
NM_010185 Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide 10.03 8.98
NM_010188 Fcgr3 Fc receptor, IgG, low affinity III 8.28 6.51
NM_013650 S100a8 S100 calcium binding protein A8 (calgranulin A) 11.50 9.08
NM_009114 S100a9 S100 calcium binding protein A9 (calgranulin B) 45.35 15.97
NM_011333 Ccl2 chemokine (C-C motif) ligand 2 48.21 10.59
NM_011124 Ccl21a chemokine (C-C motif) ligand 21A; predicted gene 1987 4.97 5.78
NM_009139 Ccl6 chemokine (C-C motif) ligand 6 16.26 13.82
NM_021443 Ccl8 chemokine (C-C motif) ligand 8 12.86 7.47
NM_011338 Ccl9 chemokine (C-C motif) ligand 9 13.72 10.02
NM_009140 Cxcl2 chemokine (C-X-C motif) ligand 2 35.49 9.30
NM_203320 Cxcl3 chemokine (C-X-C motif) ligand 3 8.58 18.49
NM_009898 Coro1a coronin, actin binding protein 1A 17.93 6.91
NM_008039 Fprl1 formyl peptide receptor 2 23.07 15.79
NM_008361 Il1b interleukin 1 beta 22.61 9.88
NM_008489 Lbp lipopolysaccharide binding protein 5.32 4.26
NM_019932 Cxcl4 platelet factor 4 6.36 15.72
NM_011335 Ccl21b chemokine (C-C motif) ligand 21B 3.80 4.56
NM_023052 Ccl21c chemokine (C-C motif) ligand 21C (leucine)    
NM_009141 Cxcl5 similar to LPS-induced CXC chemokine; chemokine (C-X-C motif) ligand 5 71.97 153.33
                The values were the geometric mean of the ratios of signal intensity of experimental sample to normal control corneas.
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2392differently  expressed.  Among  them,  586  probes  were
upregulated and 469 probes were downregulated. Similarly,
in the CB-CorNV model, 472 probes were upregulated and
389  were  downregulated,  making  a  total  of  861  probes
(12.11%) differentially expressed. Among these differentially
expressed genes, 530 probes in total overlapped in the two
models, including 286 upregulated and 244 downregulated
probes (Table 1). Some probes remained unchanged in one
model but up- or downregulated in the other model. No probes
manifested contradictory changes in the two models; namely,
no  probes  were  upregulated  in  one  model  while  being
downregulated in the other model. To allow a better overview
of  the  changes  of  all  1,386  changed  probes,  hierarchical
clustering analysis was performed, and is shown in Figure 2.
TABLE 4. GENES ASSOCIATED WITH THE GENE ONTOLOGY TERM “IMMUNE RESPONSE” IN THE UPREGULATED GENE LIST.
Ref_Seq ID Gene symbol Gene name S-CorNV
folds
CB-CorNV
folds
NM_010819 Clecsf8 C-type lectin domain family 4, member d 27.78 17.05
NM_020001 Clecsf10 C-type lectin domain family 4, member n 14.52 15.83
NM_009841 Cd14 CD14 antigen 25.69 20.90
NM_001042605 Cd74 CD74 antigen (invariant polypeptide of major histocompatibility
complex, class II antigen-associated)
2.44 3.04
NM_010185 Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide 10.03 8.98
NM_010188 Fcgr3 Fc receptor, IgG, low affinity III 8.28 6.51
NM_007388 Acp5 acid phosphatase 5, tartrate resistant 2.60 4.30
NM_011333 Ccl2 chemokine (C-C motif) ligand 2 48.21 10.59
NM_011124 Ccl21a chemokine (C-C motif) ligand 21A; predicted gene 1987 4.97 5.78
NM_009139 Ccl6 chemokine (C-C motif) ligand 6 16.26 13.82
NM_021443 Ccl8 chemokine (C-C motif) ligand 8 12.86 7.47
NM_011338 Ccl9 chemokine (C-C motif) ligand 9 13.72 10.02
FNM_009915 Ccr2 chemokine (C-C motif) receptor 2 27.51 16.93
NM_008176 Cxcl1 chemokine (C-X-C motif) ligand 1 14.52 7.16
NM_019568 Cxcl14 chemokine (C-X-C motif) ligand 14 3.34 2.30
NM_009140 Cxcl2 chemokine (C-X-C motif) ligand 2 35.49 9.30
NM_203320 Cxcl3 chemokine (C-X-C motif) ligand 3 8.58 18.49
NM_007574 C1qg complement component 1, q subcomponent, C chain 4.22 3.86
NM_007572 C1qa complement component 1, q subcomponent, alpha polypeptide 5.50 7.72
NM_009777 C1qb complement component 1, q subcomponent, beta polypeptide 5.22 5.85
NM_008147 Lilrb4 leukocyte immunoglobulin-like receptor, subfamily B, member 4 36.73 24.18
NM_010378 H2-Aa histocompatibility 2, class II antigen A, alpha; 2.53 3.32
NM_010381 H2-Ea histocompatibility 2, class II antigen E alpha 3.50 4.17
NM_207105 H2-Ab1 histocompatibility 2, class II antigen A, beta 1 4.38 4.84
NM_010382 H2-Eb1 histocompatibility 2, class II antigen E beta 3.56 4.51
NM_008361 Il1b interleukin 1 beta 22.61 9.88
NM_153511 Il1f9 interleukin 1 family, member 9 2.20 2.83
NM_008489 Lbp lipopolysaccharide binding protein 5.32 4.26
NM_019932 Cxcl4 platelet factor 4 6.36 15.72
NM_011335 Ccl21b similar to beta chemokine Exodus-2; chemokine (C-C motif) ligand
21B;
3.80 4.56
NM_009760 Bnip3 predicted gene 14506; BCL2/adenovirus E1B interacting protein 3 3.76 3.11
NM_023785 Cxcl7 pro-platelet basic protein 61.39 32.60
NM_009141 Cxcl5 similar to LPS-induced CXC chemokine; chemokine (C-X-C motif)
ligand 5
71.97 153.33
TABLE 5. GENES ASSOCIATED WITH THE GENE ONTOLOGY TERM “INFLAMMATORY RESPONSE” IN THE UPREGULATED GENE LIST.
Ref_Seq ID Gene symbol Gene name S-CorNV
folds
CB-CorNV folds
NM_010169 F2r coagulation factor II (thrombin) receptor 2.97 3.30
NM_009252 Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N 17.13 10.07
NM_009117 Saa1 serum amyloid A 1 26.09 9.43
NM_011315 Saa3 serum amyloid A 3 85.23 35.01
NM_133977 Trf transferrin 3.41 2.73
         Among all 21 genes in the GO terms of “inflammatory response,” the ones that overlapped with those in “immune response”
         were not shown, they included Cd14, Fcgr3, Ccl2, Ccl21a, Ccl8, Ccr2, Cxcl1, Cxcl2, Cxcl3, C1qg, C1qa, C1qb, Il1b, Lbp,
         Ccl21b/Ccl21c, and Cxcl5.
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2393Complimentary validation of expression patterns of VEGFA
and PEDF: It was interesting and unexpected to note that such
classical angiogenesis modulators as VEGFA and PEDF were
not among the aforementioned 1,055 genes that produced
significant alterations at mRNA levels in either CorNV model.
Studying the raw array data showed that VEGFA signals fell
below the threshold set by analysis criteria thus regarded
Absent (namely, unexpressed) in the corneas. For example,
four probes with Oligo ID being M400000704, M400000705,
M400000706, and M400000707, respectively, are included in
the array for the VEGFA gene. The signals for these four
probes in the S-CorNV group shown as “experimental sample
signal/control  sample  signal”  were  272.3±30.7/56±52.5
(mean±standard  deviation  for  three  arrays),
412.3±80.0/220.6±74.7,  159.6±43.5/31.3±161.8,  and
238.3±79.1/97.6±88.8,  respectively.  If  the  above  filtering
threshold  would  be  arbitrarily  disregarded  and  the  fold
changes provided by the automatic analysis accompanied with
the array signal results, these four probes would produce a
ratio of 2.7 for VEGFA, namely VEGFA mRNA would be
regarded upregulated by 2.7 fold in S-CorNV compared with
control corneas. On the contrary, PEDF gave high enough
signals  (between  4,000  and  6,300,  not  shown)  and  were
classified as “expressed” in all samples, the change in S-
CorNV was not significant (the experiment/control ratios in
three arrays were 0.754, 0.890, and 1.076, respectively). To
double check the expression levels of these two genes, western
blot was performed and confirmed that PEDF was expressed
at high level in normal control corneas but did not change
significantly in S-CorNV, while VEGFA showed marginal
TABLE 6. GENES ASSOCIATED WITH THE GENE ONTOLOGY TERM “REGULATION OF CYTOKINE PRODUCTION” IN THE UPREGULATED GENE LIST.
Ref_Seq ID Gene
symbol
Gene name S-CorNV
folds
CB-CorNV folds
NM_010169 F2r coagulation factor II (thrombin) receptor 2.97 3.30
NM_010442 Hmox1 heme oxygenase (decycling) 1 6.21 4.82
NM_011157 Prg serglycin 6.87 7.29
Among all 8 genes in the GO term of “regulation of cytokine production,” the ones that overlapped with those in “immune
response” were not shown, they included Cd14, Fcer1g, Fcgr3, Il1b, and Lbp.
TABLE 7. GENES ASSOCIATED WITH THE GENE ONTOLOGY TERM “BLOOD VESSEL DEVELOPMENT” THAT CHANGED IN EITHER CORNEAL NEOVASCULARIZATION
MODEL.
Ref_Seq ID Gene symbol Gene name S-CorNV
folds
CB-CorNV folds
NM_198725 Egfl7 EGF-like domain 7 4.26 3.08
NM_010228 Flt1 FMS-like tyrosine kinase 1 2.01 2.31
NM_009930 Col3a1 collagen, type III, alpha 1 12.87 16.57
NM_015734 Col5a1 collagen, type V, alpha 1 2.99 3.12
NM_010442 Hmox1 heme oxygenase (decycling) 1 6.21 4.82
NM_008361 Il1b interleukin 1 beta 22.61 9.88
NM_008610 Mmp2 matrix metallopeptidase 2 4.32 4.34
NM_007707 Socs3 suppressor of cytokine signaling 3 3.58 2.17
NM_009382 Thy1 thymus cell antigen 1, theta 3.57 2.68
NM_013749 Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a 4.08 4.81
NM_007709 Cited1 Cbp/p300-interacting transactivator with Glu/Asp-rich C-
terminal domain 1
2.54 1.00
NM_053087 Epgn epithelial mitogen 2.72 1.88
NM_009929 Col18a1 collagen, type XVIII, alpha 1 1.96 2.10
NM_030250 Nus1 nuclear undecaprenyl pyrophosphate synthase 1 homolog
(S. cerevisiae)
1.97 2.04
NM_194054 Rtn4 reticulon 4 1.72 2.48
NM_007742 Col1a1 collagen, type I, alpha 1 3.93
NM_007950 Ereg epiregulin 2.40
NM_009769 Klf5 Kruppel-like factor 5 0.36 1.40
NM_008943 Psen1 presenilin 1 0.42 0.67
NM_009154 Sema5a semaphorin, 5A 0.42 0.45
NM_016907 Spint1 serine protease inhibitor, Kunitz type 1 0.49 0.84
NM_009373 Tgm2 transglutaminase 2, C polypeptide 0.27 0.21
NM_010197 Fgf1 fibroblast growth factor 1 0.66 0.29
NM_023517 Tnfsf13 tumor necrosis factor (ligand) superfamily, member 13 0.70 0.49
NM_026924 OVOL2 ovo-like 2 (Drosophila)   0.43
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2394expression but significantly upregulated in S-CorNV (Figure
3).  The  situation  of  VEGFA  confirmed  the  rationale  that
microarray serves an effective primary screening method, and
other complementary methods would be mandatory under
some situation, like when certain highly suspected genes gave
Marginal or Absent signals in microarray assay.
Functional annotation of differentially expressed genes: The
DAVID functional annotation tool was used to annotate genes
in various groups (refer to Table 1), mainly based on the GO
biological process. The enriched GO terms in each group are
summarized in Table 2. While most of the jointly upregulated
GO terms (G1 group) were associated with “cell migration,”
“defense/immune/inflammation  responses,”  or  “tissue
development/organization/homeostasis,” the only two main
GO terms enriched in the jointly downregulated group (G7
group)  were  “oxidation  reduction”  and  “programmed  cell
death”  (Table  2).  Trying  to  reveal  common  pathways
determining development of two apparently different CorNV
models, the whole list of involved genes in several promising
GO  terms  from  Group  1  are  also  given.  They  include
“chemotaxis”  (Table  3),  “immune  response”  (Table  4),
“inflammatory  response”  (Table  5),  and  “regulation  of
cytokine production” (Table 6).
Even without going further into each gene’s function, it
could be said that the genes enriched in these groups coincided
the  events  described  above  (Table  2).  Since  blood  vessel
formation is the core component of neovascularization, we
looked  up  all  genes  that  belonged  to  the  “blood  vessel
development”  term  (Table  7)  among  all  changed  probes.
Surprisingly,  none  of  the  common  proangiogenic  or
antiangiogenic factors, such as VEGF and PEDF, appear in
this table. However, a group of lens crystallins included in the
GO term of “structural constituent of eye lens,” which has
recently  been  proven  to  be  expressed  physiologically  in
mammalian corneas [20], was among the upregulated probes
(Table 8). Most of these lens crystallin genes were upregulated
in S-CorNV at about 2–10 fold higher than in the CB-CorNV
model. By contrast, the enzyme crystallins (e.g., ALDH1A1
TABLE 8. GENES ASSOCIATED WITH THE GENE ONTOLOGY TERM “STRUCTURAL CONSTITUENT OF EYE LENS” ACCORDING TO “MOLECULAR FUNCTION” IN
UPREGULATED GENES.
Ref_Seq ID Gene symbol Gene name S-CorNV folds CB-CorNV folds
NM_013501 Cryaa crystallin, alpha A 18.90 6.31
NM_009965 Cryba1 crystallin, beta A1 9.07 4.79
NM_021541 Cryba2 crystallin, beta A2 17.96 4.06
NM_023695 Crybb1 crystallin, beta B1 20.01 4.76
NM_007773 Crybb2 crystallin, beta B2 16.68 6.51
NM_021352 Crybb3 crystallin, beta B3 10.81 3.04
NM_144761 Crygb crystallin, gamma B 12.38 4.36
NM_007775 Crygc crystallin, gamma C 39.09 4.02
NM_007776 Crygd crystallin, gamma D 16.12 4.61
NM_007777 Cryge crystallin, gamma E 14.08 3.70
NM_027010 Crygf crystallin, gamma F 14.93 4.78
NM_009967 Crygs crystallin, gamma S 29.49 6.45
TABLE 9. GENE LIST ASSOCATED WITH THE GENE ONTOLOGY TERM “OXIDATION REDUCTION” IN DOWNREGULATED GENES.
Ref_Seq ID Gene
symbol
Gene name S-CorNV
folds
CB-CorNV
folds
NM_028133 Egln3 EGL nine homolog 3 (C. elegans) 0.47 0.36
NM_008706 Nqo1 NAD(P)H dehydrogenase, quinone 1 0.26 0.33
NM_007409 Adh1 alcohol dehydrogenase 1 (class I) 0.12 0.17
NM_009626 Adh7 alcohol dehydrogenase 7 (class IV) 0.11 0.40
XM_974140 Aldh3b2 alcohol dehydrogenase 3, member b2 0.34 0.38
NM_013467 Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 0.35 0.25
NM_007436 Aldh3a1 aldehyde dehydrogenase family 3, subfamily A1 0.24 0.13
NM_013777 Akr1c12 aldo-keto reductase family 1, member C12 0.32 0.16
NM_013778 Akr1c13 aldo-keto reductase family 1, member C13 0.32 0.16
NM_023066 Asph aspartate-beta-hydroxylase 0.23 0.26
NM_007819 Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 0.44 0.29
NM_018887 Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 0.19 0.31
NM_172306 Cyp4a12 cytochrome P450, family 4, subfamily a, polypeptide 12B 0.11 0.39
NM_177406 Cyp4a12 cytochrome P450, family 4, subfamily a, polypeptide 12a 0.23 0.49
NM_025968 Ptgr1 prostaglandin reductase 1 0.25 0.14
NM_028725 Sdr42e1 short chain dehydrogenase/reductase family 42E, member 1 0.30 0.21
NM_201640 Cyp4a31 cytochrome P450, family 4, subfamily a, polypeptide 10 0.14 0.41
NM_007453 Prdx6 similar to Peroxiredoxin-6 0.30 0.38
NM_028454 Tm7sf2 transmembrane 7 superfamily member 2 0.34 0.41
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2395and ALDH3A1) which have long been proposed to be involved
in antioxidation in ocular tissues [21-23], were significantly
downregulated (Table 9). Among other genes that were listed
as downregulated in the GO term of “oxidation reduction”
(Table 9), the clustering of five members of the cytochrome
P450 family in this group is quite suggestive, since this family
has been proposed to be critical in angiogenesis, and inhibitors
of them suppress angiogenesis [24].
Table 10 further lists some genes that were significantly
changed  during  CorNV  and  deserve  further  studies.  For
example,  since  little  information  about  the  gene  Corneal
Endothelial-specific Protein-1 (NM_026358) is available and
its  function  remains  unclear  [25],  the  fact  that  it  was
downregulated in both models suggested that this gene might
be functionally involved in CorNV or that corneal endothelial
cells might be also involved in CorNV development. Besides
the genes of same family and that showed concerted changes
TABLE 10. GENES OF SPECIFIC INTEREST.
Ref_Seq ID Gene symbol Gene name S-CorNV folds CB-CorNV folds
Corneal endothelial
specific protein
NM_026358 CESP-1 Corneal endothelial-specific protein 1 0.25±0.04 0.07±0.00
Collagens
NM_009930 Col3a1 collagen, type III, alpha 1 12.94±1.69 16.90±4.05
NM_007735 Col4a4 collagen, type IV, alpha 4 0.31±0.07 0.22±0.08
NM_007737 Col5a2 collagen, type V, alpha 2 5.16±3.19 3.08±0.37
Interferon induced
proteins
NM_194069 Ifi27l1 interferon, alpha-inducible protein 27 like 1 0.41±0.04 0.39±0.08
NM_027320 Ifi35 interferon-induced protein 35 0.40±0.07 0.49±0.13
NM_133871 Ifi44 interferon-induced protein 44 0.43±0.04 0.42±0.07
NM_008331 Ifit1 interferon-induced protein with tetratricopeptide repeats 1 0.44±0.07 0.37±0.09
NM_025378 Ifitm3 interferon induced transmembrane protein 3 2.80±0.14 4.52±0.04
Keratocans
NM_008438 KERA keratocan 0.24±0.06 0.20±0.03
Keratins
NM_010662 Krt1–13 keratin 13 3.25±0.44 3.23±1.58
NM_016958 Krt1–14 keratin 14 5.80±2.16 5.08±2.95
NM_008470 Krt1–16 keratin 16 14.16±3.28 6.09±0.69
NM_010663 Krt1–17 keratin 17 10.41±1.26 8.08±1.42
NM_008471 Krt1–19 keratin 19 2.71±0.70 3.92±0.33
NM_010661 Krt12 keratin 12 0.26±0.09 0.08±0.03
NM_033373 Krt1–23 keratin 23 2.02±0.51 2.12±0.28
NM_008475 Krt2–4 keratin 4 4.76±0.73 4.49±0.17
NM_033073 Krt2–7 keratin 7 4.49±1.41 6.02±0.82
Proteinase inhibitors
XM_138237 Serpina3f serine (or cysteine) peptidase inhibitor, clade A, member 3F 9.87±3.06 7.78±0.52
NM_009252 Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N 17.36±3.33 10.30±2.67
NM_009126 Serpinb3a serine (or cysteine) peptidase inhibitor, clade B, member 3A 18.78±14.65 17.32±3.41
NM_201363 Serpinb3c serine (or cysteine) peptidase inhibitor, clade B, member 3C 20.51±11.56 27.78±5.39
NM_201376 Serpinb3d serine (or cysteine) peptidase inhibitor, clade B, member 3D 24.03±18.60 38.29±12.10
NM_011454 Serpinb6b serine (or cysteine) peptidase inhibitor, clade B, member 6b 5.28±1.79 7.55±0.79
NM_009255 Serpine2 serine (or cysteine) peptidase inhibitor, clade E, member 2 3.16±0.24 4.28±0.36
NM_009825 Serpinh1 serine (or cysteine) peptidase inhibitor, clade H, member 1 2.09±0.43 3.25±0.63
Unknown or predicted
genes
XM_135671 Predicted PHD finger protein 11 0.46±0.12 0.46±0.10
NM_183249 Predicted RIKEN cDNA 1100001G20 gene 6.73±2.53 6.55±0.85
XM_128979 Predicted RIKEN cDNA C330008K14 gene 5.99±1.76 4.15±0.81
NM_175417 Predicted RIKEN cDNA 9530008L14 gene 0.30±0.04 0.10±0.01
NM_173421 Predicted cDNA sequence BC030476 0.34±0.06 0.27±0.03
NM_029733 Predicted RIKEN cDNA 2010005H15 gene 3.72±0.56 2.21±0.40
NM_028166 Predicted RIKEN cDNA 1600014C10 gene 0.31±0.05 0.38±0.04
NM_027171 Predicted RIKEN cDNA 2310057J16 gene 0.42±0.15 0.29±0.10
XM_489536 Predicted RIKEN cDNA 6430590I03 gene 0.33±0.03 0.34±0.07
NM_134133 Predicted RIKEN cDNA 2010002N04 gene 9.75±1.85 6.34±0.66
NM_001001332 Predicted cDNA sequence BC1179090 6.73±0.98 2.99±0.35
NM_026412 Predicted DNA segment, Chr 2, ERATO Doi 750 2.76±0.67 2.21±1.00
XM_486478 Predicted ferritin light-chain 1 2.15±0.34 2.07±0.12
NM_001082547 Predicted Gm 5483 11.52±1.39 4.95±0.51
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2396(e.g., serine peptidase inhibitors), those genes that belong to
same family but manifested opposite changes in one or two
CorNV models also deserve attention. Detailed comparison
of each member of such families will help to dissect the
modulation  of  CorNV  development.  For  instance,  while
Col3a1  and  Col5a2  expression  increased  and  Col4a4
expression decreased in both models, change of keratin 12 was
also opposite to that of other genes in its family. Opposite
changes  were  also  observed  for  interferon-induced
transmembrane  protein  3  and  other  interferon-induced
proteins.  Some  hypothetical  genes  that  have  not  been
confirmed for any biologic functions by experimental study
are also listed for comparison.
Microarray analysis has been used successfully in many
studies to screen for potential key molecules during a specific
process,  such  as  infectious  keratitis  [26-28].  Aiming  at
providing  a  panorama  of  gene  changes  during  the  fast-
growing phase of CorNV, this paper does not try to provide
experimental confirmation of any proposed genes. However,
we had been successful in identifying certain potential targets
for  manipulating  CorNV  based  on  our  discovery  using
microarray profiling. For example, S100A8 and S100A9 were
first  observed  in  this  study  (Table  3).  Considering  that
S100A family members are important for neutrophil functions,
later of which are found important in CorNV development
[29], we were able to design experiments and confirm that
depleting  S100A8  inhibited  S-CorNV  [10].  We  also
previously  reported  that  the  so-called  lens  crystallins,  for
example, the α-, β-, and  γ-crystallins, were physiologically
expressed in murine corneas [20]. On the other hand, αB-
crystallin  has  been  reported  to  act  as  a  chaperone  for
VEGFA  in  angiogenesis  [30]  and  to  promote  tumor
angiogenesis  by  increasing  vascular  survival  during  tube
morphogenesis [31]. Since the current study showed that they
were significantly upregulated during CorNV, it will be worth
investigating the exact role of lens crystallins in CorNV, such
as by investigating lens crystallin-deficient animals.
Some  genes  in  the  jointly  upregulated  “immune
response” GO terms deserve special attention. For example,
the complement pathway, especially the alternative activation
pathway, has been proven to be involved in several angiogenic
conditions, including ocular neovascularization [32-34], the
most famous example being the involvement of complement
factor  H  in  the  pathogenesis  of  age-related  macular
degeneration [35]. The fact that all three types of C1q subunits
(α, β, and either γ or C) were upregulated in a similar pattern
(Table  4)  may  suggest  that  complement  pathways  were
involved  in  the  pathogenesis  of  CorNV.  Besides,  C-type
lectins, including domain family 4, member d (Clecsf8) and
member  n  (Clecsf10;  Table  4),  have  been  proven  to  be
involved in the recognition of pathogens by macrophages .
The significance of the upregulation of these genes, as well as
of those of two Fc genes (Fc receptor, IgE, high affinity I,
gamma  polypeptide  [Fcer1g]  and  Fc  receptor,  IgG,  low
affinity III [Fcgr3]) in CorNV might be due to the infiltration
of various inflammatory cells. Similarly, the study of some
genes in other groups, such as semaphorin, 5A (Sema5a)
under the “blood vessel development” GO term (Table 7) will
also be of interest. Sema5a was recently reported to promote
angiogenesis by increasing the proliferation and migration of
endothelial cells . However, we have no explanation as to why
this  gene  was  downregulated  in  such  CorNV  models.
Obviously,  the  genes  that  are  concertedly  upregulated  or
downregulated  in  both  models  might  suggest  common
pathways for the pathogenesis of these two models. However,
the genes that show differential changes in these two models
also  deserve  attention  since  they  might  determine  the
differential presentation of these two models. Furthermore,
this study also provided clues to dissecting the functions of
the “predicted genes” that were up- or downregulated.
In  summary,  we  compared  the  changes  of  genes
expression in two commonly used CorNV models and found
that while significant differences existed at the levels of gross
presentation  and  histology,  some  gene-expression  change
patterns were shared by these two CorNV models. Further
studies are needed to help define the role of some promising
genes  in  CorNV,  thereby  supplementing  our  current
understanding about the pathogenesis of neovascularization
diseases. Taking a step further, such studies might reveal new
targets  that  could  be  used  for  manipulation  of  diseases
accompanied with CorNV.
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